Catalyst Wire Dossier Catalyst Wire Dossier

APRISO 375 mg

mesalamine · Salix Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for APRISO 375 mg, covering 2018-05-08 to 2018-05-08. Get the full timeline:

Most recent: Clinical Trial Update: Randomized,Study of APRISO 375 mg Versus the Approved APRISO 375 mg Capsules in Healthy Male and Female Subjects [Phase 1]

See pricing